Trial site
Wuhan Union Hospital of China
- 14running trials
- 6closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Pancreatic cancer3 trials
- Alzheimer disease2 trials
- Bladder cancer2 trials
- Diffuse large B-cell lymphoma2 trials
- Endometrial cancer2 trials
- Ovarian cancer2 trials
- Acute myeloid leukaemia1 trial
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- and 6 more
- Phase
- Phase 28 trials
- Phase 36 trials
- Phase 1/22 trials
- Early phase 11 trial
- Phase 2/31 trial
- Status
- Completed6 trials
- Recruiting6 trials
- Active, not recruiting4 trials
- Not yet recruiting3 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Hutchmed4 trials
- Cascade Pharmaceuticals, Inc2 trials
- 3D Medicines (Sichuan) Co., Ltd.1 trial
- AbbVie1 trial
- Beijing Joekai Biotechnology LLC1 trial
- and 11 more
Running trials
Not yet recruiting
Recruiting
Recruiting
A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
Recruiting
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Recruiting
Recruiting
Recruiting
A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia
Recruiting
Active, not recruiting
CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
Active, not recruiting
CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)
Recruiting
Recruiting
Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
Enrolling by invitation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Pancreatic cancer3 recruiting
- Acute myeloid leukaemia1 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Completed
Completed
Completed
Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026